In a small study, patients with the syndrome were more likely to experience reactivation of Epstein-Barr virus and high ...
Long COVID duration did not affect health outcomes; however, COVID-19 vaccination status was associated with better PROMIS ...
Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...
When COVID-19 emerged in early 2020, it was a novel virus with no prior identification in humans. The only certainty among ...
The virus is related to the pathogen that causes Middle East respiratory syndrome and capitalizes on the same ‘entry receptor ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...